Nancy Rusch
Concepts (287)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Calcium Channels, L-Type | 10 | 2017 | 63 | 2.380 |
Why?
| Muscle, Smooth, Vascular | 15 | 2020 | 140 | 2.230 |
Why?
| Hypertension | 10 | 2019 | 564 | 1.730 |
Why?
| Muscle Contraction | 5 | 2020 | 109 | 1.670 |
Why?
| Potassium Channels, Voltage-Gated | 5 | 2018 | 14 | 1.400 |
Why?
| Blood Pressure | 6 | 2018 | 587 | 1.120 |
Why?
| Calcium | 7 | 2017 | 432 | 1.070 |
Why?
| Lymphatic Vessels | 3 | 2020 | 47 | 1.020 |
Why?
| Mesenteric Arteries | 6 | 2014 | 45 | 0.970 |
Why?
| Myocytes, Smooth Muscle | 10 | 2020 | 92 | 0.940 |
Why?
| Large-Conductance Calcium-Activated Potassium Channels | 4 | 2015 | 13 | 0.900 |
Why?
| Up-Regulation | 5 | 2013 | 508 | 0.870 |
Why?
| Vasodilation | 8 | 2020 | 106 | 0.860 |
Why?
| Coronary Vessels | 4 | 2017 | 197 | 0.850 |
Why?
| Calcium Channels | 3 | 2008 | 59 | 0.820 |
Why?
| Animals | 39 | 2023 | 14385 | 0.770 |
Why?
| Rats | 21 | 2020 | 3415 | 0.730 |
Why?
| TRPM Cation Channels | 1 | 2019 | 4 | 0.730 |
Why?
| Potassium Channels, Tandem Pore Domain | 2 | 2011 | 11 | 0.720 |
Why?
| Ryanodine Receptor Calcium Release Channel | 1 | 2019 | 12 | 0.710 |
Why?
| Muscle Cells | 1 | 2019 | 24 | 0.710 |
Why?
| Lymph | 1 | 2019 | 19 | 0.710 |
Why?
| Cerebrovascular Circulation | 3 | 2020 | 137 | 0.690 |
Why?
| Carotid Body | 1 | 2019 | 46 | 0.690 |
Why?
| Cardiovascular Diseases | 3 | 2009 | 476 | 0.690 |
Why?
| Vasodilator Agents | 3 | 2009 | 111 | 0.650 |
Why?
| Cerebral Arteries | 5 | 2020 | 37 | 0.650 |
Why?
| Receptors, Adrenergic, beta | 1 | 2018 | 41 | 0.630 |
Why?
| Doxorubicin | 1 | 2019 | 259 | 0.620 |
Why?
| Cocaine | 1 | 2018 | 184 | 0.570 |
Why?
| Estradiol | 1 | 2017 | 219 | 0.560 |
Why?
| Arteries | 3 | 2005 | 101 | 0.530 |
Why?
| Ion Channels | 2 | 2023 | 75 | 0.530 |
Why?
| Vasoconstriction | 6 | 2014 | 60 | 0.520 |
Why?
| Cardiovascular Agents | 1 | 2015 | 60 | 0.520 |
Why?
| Membrane Potentials | 8 | 2014 | 139 | 0.490 |
Why?
| Gene Expression Regulation | 6 | 2019 | 1062 | 0.470 |
Why?
| Rats, Sprague-Dawley | 12 | 2020 | 1663 | 0.470 |
Why?
| Blood Vessels | 2 | 2017 | 78 | 0.460 |
Why?
| Retinal Diseases | 2 | 2024 | 49 | 0.450 |
Why?
| Nifedipine | 2 | 2009 | 24 | 0.420 |
Why?
| Calcium Channel Blockers | 2 | 2009 | 72 | 0.400 |
Why?
| Angiotensin II | 1 | 2012 | 166 | 0.400 |
Why?
| Aorta | 2 | 2011 | 177 | 0.390 |
Why?
| Patch-Clamp Techniques | 9 | 2015 | 148 | 0.380 |
Why?
| Shaker Superfamily of Potassium Channels | 4 | 2014 | 10 | 0.380 |
Why?
| Endothelial Cells | 2 | 2023 | 294 | 0.380 |
Why?
| Genetic Therapy | 2 | 2008 | 121 | 0.370 |
Why?
| Aging | 3 | 2023 | 784 | 0.370 |
Why?
| Drug Resistance | 1 | 2009 | 74 | 0.360 |
Why?
| Coronary Circulation | 1 | 2009 | 62 | 0.350 |
Why?
| Vascular Resistance | 3 | 2017 | 60 | 0.330 |
Why?
| Potassium Channels | 2 | 2005 | 41 | 0.320 |
Why?
| alpha-Linolenic Acid | 1 | 2007 | 2 | 0.310 |
Why?
| Hypertension, Pulmonary | 1 | 2008 | 126 | 0.290 |
Why?
| Cerebellum | 1 | 2007 | 142 | 0.280 |
Why?
| Down-Regulation | 2 | 2008 | 388 | 0.280 |
Why?
| Endothelium, Vascular | 3 | 2022 | 288 | 0.270 |
Why?
| Brain Ischemia | 1 | 2007 | 169 | 0.270 |
Why?
| Serotonin | 4 | 2013 | 159 | 0.270 |
Why?
| Dose-Response Relationship, Drug | 3 | 2019 | 1476 | 0.240 |
Why?
| Diabetic Retinopathy | 1 | 2024 | 41 | 0.230 |
Why?
| Gene Expression | 2 | 2002 | 664 | 0.230 |
Why?
| Potassium Channels, Calcium-Activated | 1 | 2002 | 5 | 0.230 |
Why?
| Cells, Cultured | 4 | 2020 | 1737 | 0.230 |
Why?
| Macrophages | 2 | 2024 | 405 | 0.220 |
Why?
| Protons | 1 | 2023 | 81 | 0.220 |
Why?
| Reperfusion Injury | 1 | 2023 | 118 | 0.210 |
Why?
| Swine | 2 | 2017 | 431 | 0.210 |
Why?
| Feedback, Physiological | 1 | 2002 | 19 | 0.210 |
Why?
| TRPC Cation Channels | 2 | 2020 | 19 | 0.210 |
Why?
| Intracellular Signaling Peptides and Proteins | 2 | 2014 | 151 | 0.210 |
Why?
| Mice | 9 | 2023 | 6413 | 0.210 |
Why?
| RNA, Messenger | 5 | 2009 | 1202 | 0.210 |
Why?
| Calcium Signaling | 2 | 2013 | 59 | 0.200 |
Why?
| Humans | 19 | 2024 | 54284 | 0.200 |
Why?
| KATP Channels | 1 | 2020 | 6 | 0.190 |
Why?
| Adrenergic beta-1 Receptor Antagonists | 1 | 2020 | 6 | 0.190 |
Why?
| Large-Conductance Calcium-Activated Potassium Channel alpha Subunits | 3 | 2019 | 6 | 0.190 |
Why?
| Receptors, Adrenergic, beta-1 | 1 | 2020 | 7 | 0.190 |
Why?
| Metoprolol | 1 | 2020 | 13 | 0.190 |
Why?
| Blotting, Western | 5 | 2011 | 683 | 0.190 |
Why?
| Thiourea | 1 | 2019 | 11 | 0.180 |
Why?
| Membrane Proteins | 2 | 2014 | 389 | 0.180 |
Why?
| Edema | 1 | 2020 | 74 | 0.180 |
Why?
| Cardiotonic Agents | 1 | 2020 | 95 | 0.180 |
Why?
| Tetrazoles | 1 | 2019 | 43 | 0.180 |
Why?
| Organ Culture Techniques | 1 | 2019 | 53 | 0.180 |
Why?
| Mitochondria | 2 | 2023 | 489 | 0.180 |
Why?
| Status Epilepticus | 1 | 2020 | 37 | 0.170 |
Why?
| Male | 15 | 2023 | 27334 | 0.170 |
Why?
| Protein Subunits | 3 | 2008 | 85 | 0.170 |
Why?
| Kidney Tubules, Proximal | 1 | 2019 | 119 | 0.170 |
Why?
| Antibiotics, Antineoplastic | 1 | 2019 | 85 | 0.170 |
Why?
| Malate Dehydrogenase | 1 | 2018 | 11 | 0.160 |
Why?
| Leptin | 1 | 2019 | 154 | 0.160 |
Why?
| Mice, Inbred C57BL | 5 | 2017 | 1999 | 0.160 |
Why?
| Vascular Stiffness | 1 | 2018 | 20 | 0.160 |
Why?
| Rats, Inbred WKY | 3 | 2009 | 29 | 0.160 |
Why?
| Rats, Inbred SHR | 3 | 2009 | 33 | 0.160 |
Why?
| Microscopy | 1 | 2018 | 66 | 0.160 |
Why?
| Ion Channel Gating | 2 | 2008 | 47 | 0.150 |
Why?
| Estrogen Receptor beta | 1 | 2017 | 56 | 0.150 |
Why?
| Estrogen Receptor alpha | 1 | 2017 | 95 | 0.150 |
Why?
| Potassium Chloride | 2 | 2009 | 18 | 0.150 |
Why?
| Thioredoxins | 1 | 2017 | 30 | 0.140 |
Why?
| Nitric Oxide Synthase Type III | 1 | 2017 | 84 | 0.140 |
Why?
| Muscle, Skeletal | 1 | 2002 | 847 | 0.140 |
Why?
| Reactive Oxygen Species | 1 | 2018 | 491 | 0.130 |
Why?
| Delayed Rectifier Potassium Channels | 2 | 2005 | 2 | 0.130 |
Why?
| Pressoreceptors | 1 | 2014 | 7 | 0.130 |
Why?
| Signal Transduction | 3 | 2014 | 1753 | 0.120 |
Why?
| Mice, Knockout | 3 | 2020 | 926 | 0.120 |
Why?
| Renal Artery | 1 | 2014 | 40 | 0.120 |
Why?
| Receptor, Angiotensin, Type 1 | 1 | 2014 | 60 | 0.120 |
Why?
| Hemodynamics | 2 | 2008 | 290 | 0.120 |
Why?
| Inositol 1,4,5-Trisphosphate Receptors | 1 | 2013 | 9 | 0.120 |
Why?
| Cyclic AMP-Dependent Protein Kinases | 1 | 2014 | 56 | 0.120 |
Why?
| Fentanyl | 1 | 2014 | 34 | 0.120 |
Why?
| MicroRNAs | 1 | 2018 | 386 | 0.120 |
Why?
| Urinalysis | 1 | 2014 | 50 | 0.120 |
Why?
| Sex Characteristics | 1 | 2015 | 214 | 0.120 |
Why?
| Flow Cytometry | 2 | 2013 | 546 | 0.120 |
Why?
| Platelet Aggregation | 1 | 2013 | 82 | 0.120 |
Why?
| Polysaccharides | 1 | 2013 | 57 | 0.120 |
Why?
| Cerebrospinal Fluid | 1 | 2013 | 35 | 0.110 |
Why?
| Cell Dedifferentiation | 1 | 2012 | 9 | 0.110 |
Why?
| Carotid Arteries | 2 | 2017 | 82 | 0.110 |
Why?
| Ischemia | 2 | 2024 | 177 | 0.110 |
Why?
| Vascular System Injuries | 1 | 2012 | 37 | 0.110 |
Why?
| Temperature | 1 | 2013 | 177 | 0.110 |
Why?
| Neoplastic Cells, Circulating | 1 | 2013 | 93 | 0.110 |
Why?
| Photoacoustic Techniques | 1 | 2013 | 86 | 0.110 |
Why?
| Potassium | 2 | 2020 | 60 | 0.110 |
Why?
| Regional Blood Flow | 2 | 2014 | 121 | 0.110 |
Why?
| Cell Membrane | 2 | 2013 | 278 | 0.100 |
Why?
| Post-Synaptic Density | 1 | 2011 | 4 | 0.100 |
Why?
| Microcirculation | 2 | 2009 | 89 | 0.100 |
Why?
| Cell Movement | 1 | 2012 | 271 | 0.100 |
Why?
| Cell Line | 4 | 2019 | 1153 | 0.100 |
Why?
| Vasoconstrictor Agents | 2 | 2009 | 88 | 0.100 |
Why?
| Nanoparticles | 1 | 2013 | 173 | 0.100 |
Why?
| Stem Cells | 1 | 2012 | 193 | 0.100 |
Why?
| Enzyme Inhibitors | 2 | 2014 | 446 | 0.100 |
Why?
| Bacteria | 1 | 2013 | 258 | 0.100 |
Why?
| Muscle Proteins | 1 | 2013 | 307 | 0.100 |
Why?
| Obesity | 1 | 2019 | 1202 | 0.100 |
Why?
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2009 | 8 | 0.090 |
Why?
| Phenotype | 2 | 2012 | 820 | 0.090 |
Why?
| Mesenteric Veins | 1 | 2009 | 14 | 0.090 |
Why?
| Chelating Agents | 1 | 2009 | 28 | 0.090 |
Why?
| Large-Conductance Calcium-Activated Potassium Channel beta Subunits | 1 | 2009 | 1 | 0.090 |
Why?
| Arterioles | 1 | 2009 | 35 | 0.090 |
Why?
| Hypertension, Renovascular | 1 | 2009 | 16 | 0.090 |
Why?
| Vimentin | 1 | 2009 | 33 | 0.090 |
Why?
| Analgesics, Opioid | 1 | 2014 | 501 | 0.080 |
Why?
| Potassium Channel Blockers | 2 | 2011 | 18 | 0.080 |
Why?
| Serotonin Plasma Membrane Transport Proteins | 1 | 2009 | 51 | 0.080 |
Why?
| Pulmonary Circulation | 1 | 2008 | 36 | 0.080 |
Why?
| Cell Proliferation | 1 | 2012 | 1096 | 0.080 |
Why?
| Molecular Mimicry | 1 | 2008 | 64 | 0.080 |
Why?
| Phosphorylation | 3 | 2017 | 614 | 0.080 |
Why?
| Action Potentials | 2 | 2020 | 131 | 0.080 |
Why?
| Laser-Doppler Flowmetry | 1 | 2007 | 21 | 0.080 |
Why?
| Genetic Vectors | 1 | 2008 | 139 | 0.080 |
Why?
| Blood Flow Velocity | 1 | 2007 | 114 | 0.080 |
Why?
| Animals, Newborn | 1 | 2008 | 396 | 0.070 |
Why?
| Recombinant Fusion Proteins | 1 | 2008 | 206 | 0.070 |
Why?
| Drug Design | 1 | 2008 | 133 | 0.070 |
Why?
| Pulmonary Artery | 1 | 2008 | 151 | 0.070 |
Why?
| Mice, Transgenic | 2 | 2020 | 656 | 0.070 |
Why?
| Chronic Disease | 1 | 2008 | 614 | 0.070 |
Why?
| Anterior Cerebral Artery | 1 | 2005 | 3 | 0.070 |
Why?
| Protein Conformation | 1 | 2006 | 226 | 0.070 |
Why?
| 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid | 1 | 2005 | 7 | 0.070 |
Why?
| Cannabinoid Receptor Modulators | 1 | 2005 | 13 | 0.070 |
Why?
| Endocannabinoids | 1 | 2005 | 28 | 0.060 |
Why?
| Lung | 1 | 2008 | 507 | 0.060 |
Why?
| Myocardium | 1 | 2008 | 441 | 0.060 |
Why?
| Antihypertensive Agents | 1 | 2006 | 139 | 0.060 |
Why?
| Culture Techniques | 1 | 2004 | 21 | 0.060 |
Why?
| Mutation | 2 | 2009 | 1501 | 0.060 |
Why?
| Nitrogen | 1 | 2004 | 78 | 0.060 |
Why?
| Gene Expression Profiling | 1 | 2009 | 1138 | 0.060 |
Why?
| Ornithine Decarboxylase | 1 | 2023 | 12 | 0.060 |
Why?
| Ornithine | 1 | 2023 | 16 | 0.060 |
Why?
| Kv1.3 Potassium Channel | 1 | 2003 | 1 | 0.060 |
Why?
| Kv1.4 Potassium Channel | 1 | 2003 | 1 | 0.060 |
Why?
| Kv1.1 Potassium Channel | 1 | 2003 | 2 | 0.060 |
Why?
| Kv1.5 Potassium Channel | 1 | 2003 | 2 | 0.060 |
Why?
| Myeloid Cells | 1 | 2023 | 37 | 0.060 |
Why?
| Kv1.2 Potassium Channel | 1 | 2003 | 2 | 0.060 |
Why?
| Arginase | 1 | 2023 | 39 | 0.060 |
Why?
| Protein Structure, Quaternary | 1 | 2003 | 28 | 0.060 |
Why?
| Retina | 1 | 2024 | 64 | 0.060 |
Why?
| Triterpenes | 1 | 2003 | 13 | 0.060 |
Why?
| 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester | 1 | 2002 | 10 | 0.060 |
Why?
| Calcium Channel Agonists | 1 | 2002 | 3 | 0.060 |
Why?
| Chromatography, Liquid | 2 | 2014 | 243 | 0.050 |
Why?
| Cattle | 1 | 2002 | 224 | 0.050 |
Why?
| Mitochondrial Proteins | 1 | 2023 | 121 | 0.050 |
Why?
| Transcription, Genetic | 2 | 2014 | 418 | 0.050 |
Why?
| Glucose | 1 | 2004 | 366 | 0.050 |
Why?
| Adenosine Triphosphate | 1 | 2023 | 242 | 0.050 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2023 | 434 | 0.050 |
Why?
| NF-kappa B | 1 | 2023 | 335 | 0.050 |
Why?
| Femoral Artery | 1 | 2002 | 122 | 0.050 |
Why?
| Cromakalim | 1 | 2020 | 4 | 0.050 |
Why?
| Adrenergic beta-1 Receptor Agonists | 1 | 2020 | 3 | 0.050 |
Why?
| Minoxidil | 1 | 2020 | 7 | 0.050 |
Why?
| Diazoxide | 1 | 2020 | 6 | 0.050 |
Why?
| Dobutamine | 1 | 2020 | 24 | 0.050 |
Why?
| Pentylenetetrazole | 1 | 2020 | 9 | 0.050 |
Why?
| Norepinephrine | 1 | 2020 | 119 | 0.050 |
Why?
| Pilocarpine | 1 | 2020 | 23 | 0.050 |
Why?
| Cytokines | 1 | 2023 | 676 | 0.050 |
Why?
| Membrane Potential, Mitochondrial | 1 | 2019 | 48 | 0.050 |
Why?
| Cryopreservation | 1 | 2019 | 31 | 0.040 |
Why?
| Blood Platelets | 2 | 2013 | 269 | 0.040 |
Why?
| Heart Rate | 1 | 2020 | 357 | 0.040 |
Why?
| Epithelial Cells | 1 | 2019 | 255 | 0.040 |
Why?
| Electroencephalography | 1 | 2020 | 356 | 0.040 |
Why?
| Mesenteric Artery, Superior | 1 | 2017 | 10 | 0.040 |
Why?
| Superoxides | 1 | 2017 | 61 | 0.040 |
Why?
| Female | 1 | 2017 | 28441 | 0.040 |
Why?
| Aorta, Thoracic | 1 | 2017 | 90 | 0.040 |
Why?
| Image Processing, Computer-Assisted | 1 | 2018 | 256 | 0.040 |
Why?
| Models, Biological | 1 | 2019 | 823 | 0.030 |
Why?
| Microscopy, Immunoelectron | 1 | 2015 | 13 | 0.030 |
Why?
| Glutathione | 1 | 2017 | 330 | 0.030 |
Why?
| Oxidation-Reduction | 1 | 2017 | 382 | 0.030 |
Why?
| Genes, Reporter | 1 | 2015 | 98 | 0.030 |
Why?
| Recombinant Proteins | 1 | 2017 | 569 | 0.030 |
Why?
| GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2014 | 5 | 0.030 |
Why?
| 4-Aminopyridine | 1 | 2014 | 3 | 0.030 |
Why?
| Osmotic Pressure | 1 | 2014 | 11 | 0.030 |
Why?
| KCNQ Potassium Channels | 1 | 2014 | 3 | 0.030 |
Why?
| Anthracenes | 1 | 2014 | 13 | 0.030 |
Why?
| KCNQ3 Potassium Channel | 1 | 2014 | 6 | 0.030 |
Why?
| Hemorheology | 1 | 2014 | 14 | 0.030 |
Why?
| Losartan | 1 | 2014 | 28 | 0.030 |
Why?
| Angiotensin II Type 1 Receptor Blockers | 1 | 2014 | 46 | 0.030 |
Why?
| Myocytes, Cardiac | 1 | 2015 | 137 | 0.030 |
Why?
| N-Acetylneuraminic Acid | 1 | 2013 | 15 | 0.030 |
Why?
| NFATC Transcription Factors | 1 | 2013 | 20 | 0.030 |
Why?
| Disease Models, Animal | 1 | 2020 | 1639 | 0.030 |
Why?
| Chemical Fractionation | 1 | 2013 | 18 | 0.030 |
Why?
| Mixed Function Oxygenases | 1 | 2013 | 24 | 0.030 |
Why?
| Peptides | 1 | 2015 | 276 | 0.030 |
Why?
| HEK293 Cells | 1 | 2014 | 245 | 0.030 |
Why?
| Mammary Neoplasms, Animal | 1 | 2013 | 38 | 0.030 |
Why?
| Models, Animal | 1 | 2014 | 255 | 0.030 |
Why?
| Spectrum Analysis | 1 | 2013 | 79 | 0.030 |
Why?
| Molecular Imaging | 1 | 2013 | 60 | 0.030 |
Why?
| Staining and Labeling | 1 | 2013 | 106 | 0.030 |
Why?
| Cytochrome P-450 Enzyme System | 1 | 2014 | 192 | 0.030 |
Why?
| Calcineurin | 1 | 2013 | 70 | 0.030 |
Why?
| Cell Lineage | 1 | 2012 | 93 | 0.030 |
Why?
| Tandem Mass Spectrometry | 1 | 2014 | 248 | 0.030 |
Why?
| Mass Spectrometry | 1 | 2013 | 313 | 0.030 |
Why?
| Extracellular Matrix | 1 | 2012 | 111 | 0.030 |
Why?
| Spider Venoms | 1 | 2011 | 6 | 0.030 |
Why?
| Oligonucleotides, Antisense | 1 | 2011 | 29 | 0.030 |
Why?
| Gold | 1 | 2013 | 164 | 0.030 |
Why?
| Gene Knockdown Techniques | 1 | 2011 | 125 | 0.030 |
Why?
| Brain | 1 | 2020 | 1387 | 0.020 |
Why?
| Real-Time Polymerase Chain Reaction | 1 | 2011 | 206 | 0.020 |
Why?
| Time Factors | 1 | 2018 | 3213 | 0.020 |
Why?
| Acetylcholine | 1 | 2009 | 53 | 0.020 |
Why?
| Biotinylation | 1 | 2009 | 23 | 0.020 |
Why?
| Chromatography, Affinity | 1 | 2009 | 50 | 0.020 |
Why?
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2009 | 79 | 0.020 |
Why?
| Fluorescent Antibody Technique | 1 | 2009 | 141 | 0.020 |
Why?
| Cell Line, Tumor | 1 | 2013 | 1550 | 0.020 |
Why?
| Protein Engineering | 1 | 2008 | 21 | 0.020 |
Why?
| Peptide Fragments | 1 | 2009 | 242 | 0.020 |
Why?
| DNA, Complementary | 1 | 2008 | 145 | 0.020 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 673 | 0.020 |
Why?
| Drug Delivery Systems | 1 | 2008 | 151 | 0.020 |
Why?
| Phosphatidylethanolamines | 1 | 2005 | 13 | 0.020 |
Why?
| Diglycerides | 1 | 2005 | 12 | 0.020 |
Why?
| Isoindoles | 1 | 2004 | 2 | 0.020 |
Why?
| Organoselenium Compounds | 1 | 2004 | 2 | 0.020 |
Why?
| Uric Acid | 1 | 2004 | 32 | 0.020 |
Why?
| Free Radical Scavengers | 1 | 2004 | 35 | 0.020 |
Why?
| Azoles | 1 | 2004 | 28 | 0.020 |
Why?
| Peroxynitrous Acid | 1 | 2004 | 51 | 0.020 |
Why?
|
|
Rusch's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|